You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Phototherapeutic keratectomy with mitomycin C after Descemet stripping automated endothelial keratoplasty
  1. Teeravee Hongyok,
  2. Alisa Kim,
  3. Albert S Jun,
  4. John G Ladas,
  5. Roy S Chuck
  1. The Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA
  1. Correspondence to Dr Roy S Chuck, Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine and Montefiore Medical Center, 3332 Rochambeau Avenue, Centennial, Room 306, Bronx, NY 10467, USA; rchuck{at}montefiore.org

https://doi.org/10.1136/bjo.2009.165951

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Descemet stripping automated endothelial keratoplasty (DSAEK) has become a preferred treatment for patients with endothelial diseases, since it has many advantages over penetrating keratoplasty (PK). Severe stromal oedema and recurrent bullous keratopathy from endothelial dysfunction can cause subepithelial fibrosis (SEF)1 which can reduce optical performance after DSAEK. Phototherapeutic keratectomy (PTK) may be considered as an adjunctive procedure in these patients.

    Here, we report our first two consecutive cases of DSAEK followed by PTK with mitomycin C (MMC) for the treatment of endothelial diseases with SEF.

    Case report

    Case 1

    The right …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.